“…This is especially true in hospitals serving populations with a high caseload of COVID-19 such as in New Delhi, Mumbai, Milan, Madrid, and New York, where routine activities such as cancer screening and therapy where held up ( de Las Heras et al, 2020 ). In point of fact, surgical treatment of cancer patients utilizes substantial resources including diagnostic modalities, blood products, ICU beds and even ventilators and personal protective equipment (PPE) ( Shinde et al, 2020 ). Consequently, 70% of centers experienced a shortage in blood products and 47% to 62% of medication shortage was reported in 34 centers from 19 countries in the Middle East, North Africa, and West Asia Region ( Saab et al, 2020 ).…”